Filament Flexbox Laravel Package

Product Decisions This Supports

• Feature scoping: Likely useful for Filament admin-panel UI work, especially arranging form/schema components with flexbox layouts. v0.0.1 should be treated as a small layout utility, not a platform-level capability.
• Build vs buy: A candidate to avoid custom Blade/CSS layout wrappers for Filament admin screens, but only if source quality, tests, and maintenance activity are acceptable.
• Roadmap: Low strategic weight. It can be adopted tactically for internal tools or prototypes, but should not block core roadmap work. Pin the version and isolate usage.
• Use cases: Internal admin dashboards, rapid Filament form layout iteration, and consistent arrangement of fields/actions. Less suitable for customer-facing design systems or non-Filament UIs.
• Release signal: v0.0.1 is an initial public release with no substantive release-note detail beyond a changelog link. Treat the API as unstable until documentation and code are reviewed.

When to Consider This Package

• You are already using Filament/Laravel and need a lightweight flexbox layout helper for admin UI.
• You can tolerate pre-1.0 maturity, sparse release notes, and likely API changes.
• You will review the README, source, tests, and issue activity before merging, and pin the Composer version.
• Look elsewhere if you need stable long-term support, documented upgrade paths, accessibility/responsive guarantees, complex design-system components, or non-Filament compatibility.
• Avoid production-critical admin workflows until maintenance activity, test coverage, and issue responsiveness are verified.

How to Pitch It (Stakeholders)

Executive view: A low-cost open-source utility that may reduce custom admin UI layout work in Filament. It is not strategic, so evaluate it through a bounded pilot rather than broad adoption.

Engineering view: v0.0.1 is an initial release with no substantive changelog. Inspect the code and tests, pin the version, and contain usage behind internal admin screens. Recommend trial/prototype use only until maturity signals improve.